DENTSPLY SIRONA Inc.
| Security | XRAY / DENTSPLY SIRONA Inc. |
| Insider | Andreas G Frank |
This page shows the track record and history of FRANK ANDREAS G
insider trades in DENTSPLY SIRONA Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Andreas G Frank in XRAY / DENTSPLY SIRONA Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Andreas G Frank in XRAY / DENTSPLY SIRONA Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-15 | 2024-10-11 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 392 | 119,865 | ||||||
| 2024-07-15 | 2024-07-12 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 423 | 119,473 | ||||||
| 2024-05-14 | 2024-05-13 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 28.1800 | -2,452 | -69 | 118,814 | ||||
| 2024-05-14 | 2024-05-13 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 28.1800 | -12,118 | -341 | 121,266 | ||||
| 2024-04-15 | 2024-04-12 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 504 | 133,384 | ||||||
| 2024-03-06 | 2024-03-04 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 16,902 | 132,880 | ||||||
| 2024-03-04 | 2024-03-01 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 33.2700 | -1,507 | -50 | 115,978 | ||||
| 2024-01-16 | 2024-01-12 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 362 | 117,485 | ||||||
| 2023-11-17 | 2023-11-16 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 29.6000 | -11,216 | -332 | 117,123 | ||||
| 2023-11-17 | 2023-11-16 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 29.6000 | -2,458 | -73 | 128,339 | ||||
| 2023-10-16 | 2023-10-13 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 534 | 130,797 | ||||||
| 2023-07-17 | 2023-07-14 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 454 | 130,263 | ||||||
| 2023-04-18 | 2023-04-14 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 461 | 129,809 | ||||||
| 2023-03-07 | 2023-03-03 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 14,520 | 129,348 | ||||||
| 2023-01-13 | 2023-01-13 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 449 | 114,828 | ||||||
| 2022-11-17 | 2022-11-16 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 16,340 | 114,379 | ||||||
| 2022-11-17 | 2022-11-16 | 4 | FRANK ANDREAS G | XRAY | Common Stock | D | 98,039 | 98,039 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
